A detailed history of Clearstead Advisors, LLC transactions in Perkinelmer Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 13 shares of PKI stock, worth $1,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Holding current value
$1,573
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
N/A
13 New
13 $1,000
Q3 2023

Nov 07, 2023

BUY
$115.88 - $122.81 $2,433 - $2,579
21 New
21 $2,000
Q1 2023

May 09, 2023

BUY
$120.16 - $144.38 $961 - $1,155
8 New
8 $1,000
Q3 2021

Nov 12, 2021

SELL
$151.98 - $190.5 $93,163 - $116,776
-613 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$127.81 - $155.84 $2,172 - $2,649
17 Added 2.85%
613 $95,000
Q1 2020

May 14, 2020

BUY
$66.71 - $101.73 $39,759 - $60,631
596 New
596 $45,000

Others Institutions Holding PKI

About PERKINELMER INC


  • Ticker PKI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 126,224,000
  • Market Cap $15.3B
  • Description
  • PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...
More about PKI
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.